Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 38 (8), 767-772
- https://doi.org/10.1016/0026-0495(89)90064-4
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Chlorpropamide raises fructose-2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytesDiabetes, 1986
- Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction.Journal of Clinical Investigation, 1983
- Potentiation of insulin action by a sulfonylurea in primary cultures of hepatocytes from normal and diabetic ratsDiabetes, 1983
- The Long-term Effects of Chlorpropamide on Insulin, C-Peptide, and Proinsulin SecretionDiabetes Care, 1982
- Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulin.Journal of Clinical Investigation, 1982
- Sulphonylureas increase the number of insulin receptorsNature, 1978
- The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a mealDiabetes, 1977
- DIABETES: THE QUEST FOR BASAL NORMOGLYCÆMIAThe Lancet, 1977
- Beta-cell function improved by supplementing basal insulin secretion in mild diabetes.BMJ, 1976
- Acute and steady-state insulin responses to glucose in nonobese diabetic subjectsJournal of Clinical Investigation, 1972